Abacavir and Lamivudine 600 mg/1
Abacavir and Lamivudine · TABLET, FILM COATED · Laurus Labs Limited
No Recall History
Plain English
Abacavir and Lamivudine is a tablet, film coated containing abacavir and lamivudine at 600 mg/1, taken oral. Manufactured by Laurus Labs Limited.
Key Facts
- Brand Name
- Abacavir and Lamivudine
- Generic Name
- Abacavir and Lamivudine
- NDC Code (Product)
42385-962- Manufacturer
- Laurus Labs Limited
- Strength
- 600 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA216332
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 07/25/2022
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
exposure during pregnancy22 reports
foetal exposure during pregnancy19 reports
off label use18 reports
headache16 reports
hypersensitivity15 reports
hypertension14 reports
hepatic enzyme increased13 reports
nausea13 reports
rash13 reports
pain12 reports
Frequently Asked Questions
What is Abacavir and Lamivudine used for?
Abacavir and Lamivudine contains Abacavir and Lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Abacavir and Lamivudine a controlled substance?
Abacavir and Lamivudine is not classified as a controlled substance by the DEA.
What is the generic name for Abacavir and Lamivudine?
The generic name for Abacavir and Lamivudine is Abacavir and Lamivudine. There are 1 other brand versions of Abacavir and Lamivudine.
What is the NDC code for Abacavir and Lamivudine 600 mg/1?
The NDC (National Drug Code) for Abacavir and Lamivudine 600 mg/1 is 42385-962, listed by Laurus Labs Limited.